$BOLT
Bolt Biotherapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$3.35
▲+0.00%+$0.000
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateBolt Biotherapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is BOLT up today? It is at $3.35 (+0.00%), and our scanner flagged it 1 time on unusual volume this month. See the catalyst behind the move, real-time alerts the moment BOLT spikes, and full due diligence on BOLT — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $BOLT 1 time in the last 30 days. Create a free account to track $BOLT, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on BOLT from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for BOLT today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Nemec Sarah Officer | Bought (open market) | +125 | added 9.7% | 1K | $576 at $4.61 | Dec 5, 25 |
Quinn William P. Officer | Bought (open market) | +125 | added 5.7% | 2K | $576 at $4.61 | Dec 5, 25 |
Quinn William P. Officer | Acquired (grant/award) | +40K 2.1% of company | added 100% | 42K | n/a | Oct 22, 25 |
Yonehiro Grant Officer | Acquired (grant/award) | +30K 1.6% of company | added 100% | 39K | n/a | Oct 22, 25 |
Nemec Sarah Officer | Acquired (grant/award) | +23K 1.2% of company | added 100% | 24K | n/a | Oct 22, 25 |
Quinn William P. Officer | Bought (open market) | +125 | added 6.1% | 2K | $686 at $5.49 | Jun 6, 25 |
Nemec Sarah Officer | Bought (open market) | +125 | added 15% | 943 | $686 at $5.49 | Jun 6, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on BOLT from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for BOLT today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
BOLT last traded at $3.35, up 0.00% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Bolt Biotherapeutics, Inc. Common Stock (BOLT) is next expected to report earnings on Wednesday, November 11, 2026, about 54 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The BOLT Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged BOLT 1 time in the last 30 days.
BOLT (Bolt Biotherapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $7M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge BOLT for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$BOLT discussion
Sign in to ask a question or join the discussion.